Cystic fibrosis (CF) and pulmonary fibrosis (PF) are two chronic conditions that damage the lungs. Treatment for both aims to improve breathing, manage symptoms, and prevent further lung damage. Your ...

Yale researchers have identified a possible driver of the persistent inflammation that causes irreversible lung damage in patients with cystic fibrosis, a genetic disorder that impairs breathing and ...

New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...

Advances in patient screenings and breakthrough therapies allow Cystic fibrosis (CF) patients now to live into their mid-to-late 30s or 40s, sometimes even longer. However, even the ~90% of patients ...

Caleigh has struggled most of her life with a difficult lung disease, but she never lets it get the best of her.

(BOSTON) — The inherited progressive disorder cystic fibrosis (CF) causes severe damage to the lungs, and other tissues in the body by affecting the cells that produce mucus, sweat, and digestive ...

Please provide your email address to receive an email when new articles are posted on . Patients with cystic fibrosis are susceptible to serious lung infections. Delivering antibiotics through liquid ...

For young people with cystic fibrosis, lung infection with Staphylococcus aureus, MRSA, is common and is treated with antibiotics in the hope that this will prevent a decline in lung function. However ...

Chest physiotherapy is a common treatment for cystic fibrosis that involves breathing exercises and specialized devices. Often, people with cystic fibrosis are taught how to do chest physiotherapy on ...

Shares of Arcturus Therapeutics ARCT have plunged 59.4% in the past three months. The massive stock price drop was primarily ...

For young people with cystic fibrosis, lung infection with Staphylococcus aureus, MRSA, is common and is treated with antibiotics in the hope that this will prevent a decline in lung function. However ...

Despite advances in patient screenings and breakthrough therapies that allow CF patients now to live into their mid- to late 30s or 40s, sometimes even longer, all patients are plagued by bacteria ...